Diebold Nixdorf, Incorporated (DBD) financial statements and ratios from SEC XBRL: revenue $3.81B (TTM), net margin 2.5%, revenue growth 1.7% YoY, P/E 20.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.81B |
| Net Margin | 2.5% |
| Revenue Growth (YoY) | 1.7% |
| EPS Growth (YoY) | 36.4% |
| P/E Ratio | 20.7 |
| EV / EBITDA | 7.6 |
| Price / Book | 2.36 |
| Price / Sales | 0.59 |
| DCF Value (model) | $50.49 |
| DCF Upside vs Price | -25.5% |
| Altman Z-Score | 1.88 (grey) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Technology) | 33.9 |
DBD overview · DBD earnings · DBD KPIs · DBD investor relations · DBD ownership · DBD peers · DBD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.